MEI Pharma, Inc. (MEIP)

NASDAQ: MEIP · Real-Time Price · USD

7.02

+0.47 (7.18%)

Jul 22, 2025, 3:08 PM - Market open

Revenue by Product

Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2017 - 2019
Pharmaceutical Compounds	752.00K	Log In	Log In	Log In	Log In	Upgrade
Pharmaceutical Compounds Growth	-98.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2017 - 2019
United States	752.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-98.46%	Log In	Log In	Log In	Log In	Upgrade